JM
Jesse McGreivy at Kartos Therapeutics
Developer of an MDM2 inhibitor intended to improve the lives of patients with cancer
ContactFirm
Kartos Therapeutics
Location
Global
Investment Stage
Growth
Geographic Focus
Global
About Jesse McGreivy
Enriching content...
Similar Investors in Global
Contact Kartos Therapeutics
Get in touch for investment criteria and partnership opportunities.
Contact